Atlas Trials

Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients

Clinical trial NCT04242004 · UNKNOWN

Trial details

NCT number
NCT04242004
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neurocognitive Impairment
Start date
2019-10-30
Primary completion
2020-03-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.